In contrast, in CACNA1G-AS1-overexpressing ovarian cancer cells, FTH1 and IGF2BP1 expression obviously increased, while IGF2BP1 downregulation reversed this change (consistent with IGF2BP1, Figs. 2D and 2E). The gene discussed is FTH1; the disease is ovarian cancer.